|Articles|May 12, 2011
Ending drug companies' addiction to price rises
NEW YORK (Reuters) - Drug companies are dosing up on price increases to prop up stagnant sales, but will soon need to break that addiction as more medicines face generic competition.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
2
White House Announces Action to Increase Competition, Decrease Cost of Biosimilar Development
3
How PBMs Legally Challenged Arkansas’ Pharmacy Ownership Law | NCPA 2025
4
Pioglitazone Added to Metformin, Dapagliflozin Lowers Glucose for Patients With Diabetes
5





















































































































































